Abstract

Recent genome-wide association studies (GWAS) have yielded a bounty of single nucleotide polymorphisms (SNP)s related to Alzheimer's disease (AD) or conditions associated with AD. Here, we will present several vignettes that illustrate approaches to use these results to clarify AD-related pathways and potential therapeutics

Document Type

Presentation

Publication Date

2-7-2012

Notes/Citation Information

Published in Molecular Neurodegeneration, v. 7 (Suppl. 1): L12.

© 2012 Estus; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

From 2011 International Conference on Molecular Neurodegeneration (Shanghai, China: 22-24 September 2011).

Digital Object Identifier (DOI)

http://dx.doi.org/10.1186/1750-1326-7-S1-L12

Included in

Geriatrics Commons

Share

COinS